ClinicalTrials.Veeva

Menu

COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor (COVID-BioB)

U

Università Vita-Salute San Raffaele

Status

Enrolling

Conditions

Coronavirus Infections

Treatments

Other: Observational Study

Study type

Observational

Funder types

Other

Identifiers

NCT04318366
COVID-BioB/OSR

Details and patient eligibility

About

Collection and analysis of demographic, clinical, radiographic and laboratory characteristics of CoViD-19 patients to identify predictors of disease severity, mortality and treatment response, and to identify subgroup of patients that might benefit from specific therapeutic interventions

Enrollment

6,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients admitted to hospital with biological samples positive for SARS-CoV-2
  • Patients admitted to hospital with negative test but clinical and radiological characteristics highly suggestive of SARS-CoV-2 disease
  • Patients discharged from emergency department with biological samples positive for SARS-CoV-2

Exclusion criteria

  • None

Trial design

6,000 participants in 1 patient group

COVID-19 patients
Treatment:
Other: Observational Study

Trial contacts and locations

13

Loading...

Central trial contact

Giovanni Landoni, Professor; Alberto Zangrillo, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems